Step 1 topics → Microbiology → Hepatitis B Virus

Hepatitis B Virus

USMLE Step 1 trap: Misses the window period where only anti-HBc IgM is positive and HBsAg is already negative. During the window period of acute HBV infection, HBsAg has cleared but anti-HBs has not yet appeared; anti-HBc IgM is the only positive marker and confirms acute infection.

Hepatitis B virus (HBV) is a partially double-stranded DNA virus and one of the highest-yield microbiology topics on USMLE Step 1. The most commonly missed serology pattern is the window period: HBsAg has cleared but anti-HBs hasn't appeared yet — the only positive marker is anti-HBc IgM. Students who only know 'HBsAg positive = infected' will call a window-period patient uninfected and miss an acute HBV case entirely. Beyond serology, the age-at-infection rule is counterintuitive and specifically tested: neonates infected perinatally develop chronic HBV ~90% of the time, while healthy adults clear the infection >95% of the time — immune maturity at first exposure drives this, not general immune 'strength.'

The trickiest part is that USMLE Step 1 loves edge cases where the obvious interpretation is wrong. The window period is the classic trap: HBsAg has cleared, anti-HBs hasn't appeared yet, and the only positive marker is anti-HBc IgM. Students who only memorize 'HBsAg positive = infected' will call this patient uninfected and miss it completely. Similarly, anti-HBs positivity does NOT automatically mean prior natural infection — it also appears post-vaccination, and the distinction hinges entirely on whether anti-HBc is co-positive. A vaccinated person will be anti-HBs positive but anti-HBc negative, full stop.

Beyond serology, know the age-at-infection rule cold: neonatal infection carries ~90% chronicity risk, healthy adult infection carries only ~5%. This is counterintuitive and the exam exploits students who reverse it. The HBV vaccine composition (recombinant HBsAg subunit, no live virus, no viral DNA) is also fair game — confusing it with live attenuated vaccines has real clinical implications and Step 1 will test whether you know the distinction.

From real student decks
76%have cards covering this topic
57%have mature cards
1.0median lapses in 14 days

Common misconceptions

Common mistake
Wrong: A patient is uninfected if HBsAg is negative.
Right: During the window period of acute HBV infection, HBsAg has cleared but anti-HBs has not yet appeared; anti-HBc IgM is the only positive marker and confirms acute infection.
HBsAg becomes undetectable before anti-HBs appears — this gap is called the window period, and it's when students get burned. During this time, the patient is still actively infected and anti-HBc IgM is the only positive marker. If you call a window-period patient uninfected because HBsAg is negative, you've missed an acute HBV case; always check anti-HBc IgM when the serology looks 'blank.'
Common mistake
Wrong: Anti-HBs positivity always indicates prior natural infection.
Right: Anti-HBs alone (without anti-HBc) indicates vaccine-induced immunity; anti-HBs with anti-HBc indicates prior natural infection and recovery.
Anti-HBs is the neutralizing antibody, but it doesn't tell you how it got there on its own. Vaccination produces anti-HBs without ever generating anti-HBc, because the immune system only sees HBsAg — there's no viral core antigen involved. Natural infection produces both anti-HBs and anti-HBc, so the co-presence of anti-HBc (especially IgG) confirms prior true infection rather than vaccination.
Common mistake
Wrong: Adults are more likely than neonates to develop chronic HBV infection.
Right: Neonates infected perinatally have a ~90% risk of chronic HBV, while immunocompetent adults who acquire HBV have only a ~5% risk of chronicity.
Neonatal immune systems are immunologically immature and mount a tolerogenic response to HBV rather than clearing it, which is why ~90% of perinatally infected neonates develop chronic infection. Healthy adults have fully competent immune systems and clear acute HBV over 95% of the time, leaving only ~5% progressing to chronicity. Students reverse this because it seems counterintuitive — being older and 'stronger' should mean better outcomes — but here, immune maturity at the time of first exposure is everything.
Common mistake
Wrong: The HBV vaccine contains live attenuated virus.
Right: The HBV vaccine is a recombinant subunit vaccine containing only HBsAg produced in yeast; it contains no viral DNA or live virus.
The HBV vaccine contains only recombinant HBsAg protein expressed in yeast — there is no viral DNA, no nucleocapsid, no live virus, and no inactivated virus present. This means it cannot cause infection, cannot cause a positive HBsAg test more than a day or two post-vaccination, and is safe in immunocompromised patients. Classifying it as live attenuated is wrong and matters clinically: live vaccines are contraindicated in pregnancy and immunosuppression, but the HBV recombinant vaccine is not.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a serologic panel showing combinations of HBsAg, anti-HBs, anti-HBc IgM/IgG, and HBeAg, identify the correct disease state — acute infection, window period, resolved infection, chronic infection, or vaccine-induced immunity.
  2. Predict the likelihood of chronic HBV infection based on the age and immune status of the patient at time of infection, particularly contrasting neonatal versus adult-acquired disease.
  3. Distinguish between acute HBV (self-limited, supportive care) and chronic HBV (antivirals such as tenofovir or entecavir) in terms of management, and correctly classify the HBV vaccine as a recombinant subunit vaccine rather than a live or inactivated product.

Can you avoid these mistakes?

A patient's HBV panel shows: HBsAg negative, anti-HBs negative, anti-HBc IgM positive, anti-HBc IgG negative, HBeAg negative. What is the diagnosis and what should you do next?
A healthcare worker gets routine HBV serology after completing the vaccine series and shows: HBsAg negative, anti-HBs positive, anti-HBc negative. A colleague says this indicates prior natural infection. Are they right? Why or why not?
A pregnant woman with known chronic HBV delivers a neonate. Without intervention, approximately what percentage chance does this neonate have of developing chronic HBV, and why is this risk so different from an adult who acquires HBV sexually?
A patient with chronic HBV asks about treatment. You explain that the approach differs from acute HBV — walk through what you would offer for each scenario, and explain what the HBV vaccine is made of and why it cannot cause HBV infection.

Related topics

Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →